Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • S115: CONSOLIDATION WITH BLINA...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
S115: CONSOLIDATION WITH BLINATUMOMAB IMPROVES OVERALL AND RELAPSE-FREE SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: IMPACT OF AGE AND MRD LEVEL IN ECOG-ACRIN E1910

S115: CONSOLIDATION WITH BLINATUMOMAB IMPROVES OVERALL AND RELAPSE-FREE SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: IMPACT OF AGE AND MRD LEVEL IN ECOG-ACRIN E1910

Bibliographic Details
Main Authors: Mark Litzow, Zhuoxin Sun, Ryan Mattison, Elisabeth Paietta, Charles Mullighan, Kathryn Roberts, Yanming Zhang, Janis Racevskis, Cheryl Willman, Matthew Wieduwilt, Michaela Liedtke, Julie Bergeron, Hillard Lazarus, Dan Arber, Brent Wood, Jacob Rowe, Keith Pratz, Shira Dinner, Noelle Frey, Steve Gore, Bhavana Bhatnagar, Ehab Atallah, Geoff Uy, Deepa Jeyakumar, Tara Lin, Shejal Patel, Michelle Elliott, Anjali Advani, Daniel Deangelo, Dimitrios Tzachanis, Pankit Vachhani, Rupali Bhave, Richard Little, Harry Erba, Richard Stone, Selina Luger, Martin Tallman
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000967372.19440.62
  • Holdings
  • Description
  • Similar Items
  • Staff View
Description
ISSN:2572-9241

Similar Items

  • Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900
    by: Hugo F. Fernandez, et al.
    Published: (2019-04-01)
  • A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B‐cell or T‐cell acute lymphoblastic leukemia: Results from the ECOG‐ACRIN EA9152 protocol
    by: Neil D. Palmisiano, et al.
    Published: (2024-10-01)
  • Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999
    by: Franck Rapaport, et al.
    Published: (2022-09-01)
  • Results of ECOG-ACRIN E2108 Trial: Is This the End of Primary Surgery in Metastatic Breast Cancer?
    by: Paulo Luz
    Published: (2021-01-01)
  • Correction: Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999
    by: Franck Rapaport, et al.
    Published: (2023-07-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs